title: Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion.
authors.affiliation: emmanuelle.clappier@rdb.aphp.fr.
authors.forename: Etienne
authors.initials: E
authors.lastname: Lengline
authors.forename: Kheïra
authors.initials: K
authors.lastname: Beldjord
authors.forename: Hervé
authors.initials: H
authors.lastname: Dombret
authors.forename: Jean
authors.initials: J
authors.lastname: Soulier
authors.forename: Nicolas
authors.initials: N
authors.lastname: Boissel
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Clappier
mesh_terms: D000293:Adolescent; D001549:Benzamides / Q000627:therapeutic use*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000235:genetics* / Q000378:metabolism; D015534:Trans-Activators / Q000235:genetics* / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D001549:Benzamides; C081976:EBF1 protein, human; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D015534:Trans-Activators; D000068877:Imatinib Mesylate; D020797:Receptor, Platelet-Derived Growth Factor beta
keywords: B-cell precursor acute lymphoblastic leukemia; EBF1-PDGFRB; refractory; tyrosine kinase inhibitor